Ledger.Open graph →
SEC Form D · filed August 11, 2020

Akers Biosciences, Inc

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Other Health Care
Location
THOROFARE, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Howard Yeaton · Thorofare, NJExecJoshua C. Silverman · Thorofare, NJDirectorBill J. White · Thorofare, NJDirectorRobert C. Schroeder · Thorofare, NJDirectorChristopher C. Schreiber · Thorofare, NJExec · DirectorGreg Cole · Lehi, UTExec · Directorvan Biema Value Partners, LLC · New York, NYDirectorStephen Dalby · Lehi, UTDirectorJeff Siegel · Huntsville, UTExecvan Biema & Company, LLC · New York, NYDirectorKenneth Berlin · Monmouth Junction, NJDirectorDavid Sidransky · Monmouth Junction, NJDirectorJames Patton · Monmouth Junction, NJExecDevin Antin · Playa Vista, CADirectorBrennen Degner · Playa Vista, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗